KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 17.86% |
| Q3 2025 | -6.67% |
| Q2 2025 | -14.13% |
| Q1 2025 | -1.10% |
| Q4 2024 | -4.60% |
| Q3 2024 | 14.71% |
| Q2 2024 | -21.43% |
| Q1 2024 | -5.00% |
| Q4 2023 | -8.11% |
| Q3 2023 | 36.75% |
| Q2 2023 | -129.41% |
| Q1 2023 | 32.00% |
| Q4 2022 | 20.21% |
| Q3 2022 | -4.44% |
| Q2 2022 | 2.17% |
| Q1 2022 | -15.00% |
| Q4 2021 | -21.21% |
| Q3 2021 | 0.00% |
| Q2 2021 | -17.86% |
| Q1 2021 | 3.45% |
| Q4 2020 | 4.92% |
| Q3 2020 | -64.86% |
| Q2 2020 | 28.85% |
| Q1 2020 | -57.58% |
| Q4 2019 | 21.43% |
| Q3 2019 | 16.00% |
| Q2 2019 | -117.39% |
| Q1 2019 | -4.55% |
| Q4 2018 | 53.19% |
| Q3 2018 | -673.03% |
| Q2 2018 | 87.59% |
| Q1 2018 | 2.00% |
| Q4 2017 | 1.96% |
| Q3 2017 | -18.60% |
| Q2 2017 | 57.00% |
| Q1 2017 | -12.46% |
| Q3 2016 | -77.84% |
| Q2 2016 | 85.75% |
| Q1 2016 | -16.61% |
| Q4 2015 | -13.58% |